Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,252.20
Bid: 1,253.20
Ask: 1,253.60
Change: 0.00 (0.00%)
Spread: 0.40 (0.03%)
Open: 1,248.00
High: 1,255.60
Low: 1,221.60
Yest. Close: 1,243.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

RNS Alerts are a premium feature

Login to your account

myTerminal is a premium feature

Login to your account

Don't have an account? Click here to register.

UPDATE 2-Gay juror's ouster forces new U.S. trial between GSK, Abbott

* Glaxo had sought $571 million, was awarded $3.5 mln * Abbott excluded juror because of sexual orientation * Ruling shows influence of recent Supreme Court opinion By Dan Levine SAN FRANCISCO, Jan 21 (Reuters) - A gay man was improperly excluded from jury service because

21 Jan 14 21:10

UPDATE 1-Exclusion of gay juror forces new U.S. trial between GSK, Abbott

By Dan Levine SAN FRANCISCO, Jan 21 (Reuters) - GlaxoSmithKline Plc deserves a new trial against Abbott Laboratories because Abbott impermissibly excluded a potential juror based on his sexual orientation, a federal appeals court ruled on Tuesday. The case involved Abbott's pricing

21 Jan 14 18:31

GSK gets new trial against Abbott over gay juror issue -U.S. court

SAN FRANCISCO, Jan 21 (Reuters) - GlaxoSmithKline Plc deserves a new trial against Abbott Laboratories because Abbott impermissibly excluded a potential juror based on his sexual orientation, a federal appeals court ruled on Tuesday. GSK had won a jury verdict for about $3.5 million again

21 Jan 14 17:35

London close: FTSE 100 treads water at eight-month high

- FTSE 100 fails to break 2013 intraday high - Credit squeeze eases in China - IMF lifts global growth forecasts techMARK 2,846.40 -0.25% FTSE 100 6,834.26 -0.04% FTSE 250 16,144.20 -0.51% After a choppy session, UK markets finished broadly flat on Tuesday as the FTSE 100 teetered at levels not re

21 Jan 14 16:38

GlaxoSmithKline wins approval for new HIV drug

Drugs maker GlaxoSmithKline rose after reporting that its new HIV treatment, Tivicay, has received approval in Europe. The drug is manufactured by ViiV Healthcare, a company in which GSK, Pfizer and Shionogi are shareholders. Tivicay is for use in combination with other anti-retroviral medicinal

21 Jan 14 15:23

FTSE 100 movers: Intertek jumps on readacross from SGS

Intertek, a provider of testing and safety solutions, jumped as a result of readacross from its sector peer, Swiss firm SGS, which posted upbeat full-year results. Consumer products group Unilever was also high riser today after reporting underlying sales growth of 4.3% for 2013, helped by strong

21 Jan 14 15:09

CORRECT: UK MIDDAY BRIEFING: Unilever Kicks Off New Earnings Season

(An item published at 1259 GMT misstated the market prices. The correct version follows.) LONDON (Alliance News) - Anglo-Dutch consumer goods and food giant<strong> Unilever</strong> Tuesday kicked off the latest UK earnings season, reporting lower revenues for the fourth quarter and who

21 Jan 14 13:03

UK MIDDAY BRIEFING: Unilever Kicks Off New Earnings Season

LONDON (Alliance News) - Anglo-Dutch consumer goods and food giant<strong> Unilever</strong> Tuesday kicked off the latest UK earnings season, reporting lower revenues for the fourth quarter and whole of 2013, but its earnings beat expectations as margins were supported by price increases and

21 Jan 14 12:59

Glaxo Joint Venture ViiV Healthcare HIV Treatment Approved In Europe

LONDON (Alliance News) - GlaxoSmithKline PLC said Tuesday that its joint venture Viiv Healthcare Ltd saw its Tivicay integrase inhibitor approved for use in combination with other anti-retroviral medicinal products for the treatment of HIV by the European Commission. This regulation authori

21 Jan 14 12:01

DIRECTOR DEALINGS: GlaxoSmithKline Executive Allocated ADSs

LONDON (Alliance News) - Healthcare and pharmaceuticals giant GlaxoSmithKline PLC Monday said that Executive Director Moncef Slaoui was allocated 15 American Depositary Shares at a price of USD54.10 each on January 17. Glaxo shares closed at 1,657.68 pence per share Monday, up 0.8%. B

20 Jan 14 17:41

UK BROKER RATING CHANGES: CS Raises Hargreaves Lansdown To Neutral

LONDON (Alliance News) - The following UK shares received analyst recommendations Monday morning and Friday afternoon:<br />----------<br /><strong>FTSE 100</strong><br />----------<br />CREDIT SUISSE RAISES NEXT PRICE TARGET TO 6500 (5500) PENCE - 'NEUTRAL' <br />----------<br />BERENBERG RAI

20 Jan 14 10:05

STOCKS NEWS EUROPE-Major drugmakers to post 4 pct sales growth-CS

Credit Suisse predicts major European drugmakers will report 4 percent sales growth and 6 percent earnings per shares (EPS) growth this year, with companies such as Bayer and Novartis seen outperforming the market. It expects that Roche will also do well. "EU Pharma benefitted from a

20 Jan 14 09:35

DIRECTOR DEALINGS: Glaxo Executives Acquire ADSs

LONDON (Alliance News) - GlaxoSmithKline PLC Friday said Deidre Connelly, divisional president and Bill Louv, divisional senior vice president bought American Depositary shares following the re-investment of dividends January 9.<br /><br />Details are as follows. &nbsp; <table class="

17 Jan 14 17:08

MARKET PULSE-Best Buy, Citi, Prosensa, Sarepta, Rentrak, Alamos Gold

(For more market insights, including options activity, click on ; for the Day Ahead newsletter http://link.reuters.com/mex49s; for the Morning News Call newsletter, http://link.reuters.com/nex49s) U.S. stocks fell on Thursday, with the S&P 500 pulling back from record levels following a round

16 Jan 14 20:00

MARKET PULSE-Best Buy, Citi, Prosensa, Sarepta, Rentrak, Alamos Gold

(For more market insights, including options activity, click on ; for the Day Ahead newsletter http://link.reuters.com/mex49s; for the Morning News Call newsletter, http://link.reuters.com/nex49s) U.S. stocks fell on Thursday, with the S&P 500 pulling back from record levels following a round

16 Jan 14 18:26

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.